TRACON Pharmaceuticals, Inc. announced that Bonne Adams notified the company that she will be resigning from her position as Chief Operating Officer of the Company, effective October 15, 2023, through which time Ms. Adams will assist with an orderly transition of her duties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | -6.54% | -25.91% | -59.17% |
05-14 | Transcript : TRACON Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Earnings Flash (TCON) TRACON PHARMACEUTICALS Posts Q1 Revenue $100,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.17% | 3.48M | |
-2.32% | 92.59B | |
+3.68% | 41.43B | |
-10.90% | 33.49B | |
-19.56% | 14.62B | |
-9.06% | 12.77B | |
-11.34% | 11.58B | |
-43.53% | 11.35B | |
+3.75% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- TCON Stock
- News TRACON Pharmaceuticals, Inc.
- TRACON Pharmaceuticals, Inc. Announces Resignation of Bonne Adams as Chief Operating Officer, Effective October 15, 2023